Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by a mutation in the HTT gene, leading to the production of a toxic huntingtin protein that progressively damages nerve cells in the brain. HD is characterized by uncontrolled movements (chorea), cognitive decline, and psychiatric symptoms.
Germany is at the forefront of HD research and treatment, offering advanced diagnostics, disease-modifying drugs, gene therapy, stem cell therapy, and specialized neurorehabilitation programs to slow disease progression and improve quality of life.
At WEGOVITA, we connect patients with Germany’s top neurologists, movement disorder specialists, and HD research centers, ensuring personalized and comprehensive Huntington’s disease care
📍 Phase 1: Pre-Arrival Services (Before Coming to Germany)
Virtual consultation with Germany’s leading Huntington’s specialists & movement disorder experts..
Review of genetic tests, MRI, PET scans, and cognitive assessments.
Personalized treatment plan based on disease stage and symptoms.
Visa assistance, accommodation arrangements, and airport-hospital transfers.
📍 Phase 2: Advanced Diagnostics & Disease Staging
Germany provides high-precision neurodiagnostics to confirm Huntington’s disease diagnosis and assess disease progression.
Genetic Testing for HTT Mutation – Confirms Huntington’s disease diagnosis.
MRI & Functional MRI (fMRI) – Identifies brain atrophy, particularly in the striatum